Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
AOD-9604 FDA Approval History At a glance FDA approval status / Never approved for any indication in the United States NDA filing history / No New Drug Application has ever been submitted to FDA Chemical identity / Synthetic peptide corresponding to amino acids 176-191 of human growth hormone, with a tyrosine residue added at the C-terminus Developer / Metabolic Pharmaceuticals Ltd (Melbourne, Australia), now defunct Clinical trial outcome / Phase IIb trial (2007) failed to meet primary efficacy endpoint for obesity FDA compounding status / Placed on Category 2 list
Human evidence included randomized trials, cohort studies, case-control studies, case series, and case reports
Endotoxin levels are below 1 EU/mg so its safe for sensitive cell culture applications without risking experimental contamination
Nutrition: Keep protein intake adequate to give tissue repair the building blocks it needs
Without enough NAD+, cells cannot keep up with their own energy demands, which is why the molecule is so closely tied to how energized and clear headed you feel
US$ 20.57
US$ 28.15
US$ 25.97
US$ 21.02
US$ 27.75
US$ 26.25
US$ 25.31
US$ 26.38
US$ 25.20
US$ 24.94